Missed hypereosinophilic syndrome in a critically ill patient with systemic lupus erythematosus.
Aged
Antiphospholipid Syndrome
/ complications
Cardiomyopathies
/ blood
Creatine Kinase
/ blood
Critical Illness
Exanthema
/ etiology
Glucocorticoids
/ therapeutic use
Humans
Hypereosinophilic Syndrome
/ diagnosis
Immunosuppressive Agents
/ therapeutic use
Ischemic Stroke
/ diagnostic imaging
Leukocyte Count
Lupus Erythematosus, Systemic
/ complications
Magnetic Resonance Imaging
Male
Missed Diagnosis
Paresis
/ etiology
Sleepiness
Tomography, X-Ray Computed
Troponin
/ blood
haematology (incl blood transfusion)
stroke
systemic lupus erythematosus
Journal
BMJ case reports
ISSN: 1757-790X
Titre abrégé: BMJ Case Rep
Pays: England
ID NLM: 101526291
Informations de publication
Date de publication:
28 Jan 2021
28 Jan 2021
Historique:
entrez:
29
1
2021
pubmed:
30
1
2021
medline:
4
3
2021
Statut:
epublish
Résumé
A high functioning 74-year-old man with systemic lupus erythematosus presented to the emergency department with acute anxiety. He was found to have elevated cardiac enzymes and admitted to the cardiology service for investigation. In hospital, he developed an erythematous papular rash, and deteriorated to being somnolent and bedridden. He was found to have new multiterritory ischaemic strokes. It was eventually noted that he had persistent eosinophilia, present even on admission, which had been overlooked as the total leucocyte count was normal. Serology for antiphospholipid antibody syndrome (APS) was positive. He was diagnosed with hypereosinophilic syndrome (HES) secondary to new APS, and responded to high-dose steroids. This case highlights the importance of fully evaluating a leucocyte differential to make a diagnosis of HES. We discuss the definition, clinical manifestations, diagnostic approach and management of this important condition.
Identifiants
pubmed: 33509859
pii: 14/1/e236592
doi: 10.1136/bcr-2020-236592
pmc: PMC7845666
pii:
doi:
Substances chimiques
Glucocorticoids
0
Immunosuppressive Agents
0
Troponin
0
Creatine Kinase
EC 2.7.3.2
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Curr Opin Infect Dis. 2012 Aug;25(4):458-63
pubmed: 22691685
West Indian Med J. 2009 Jan;58(1):69-71
pubmed: 19566003
J Allergy Clin Immunol. 1990 Aug;86(2):202-10
pubmed: 2200820
Prim Care. 2016 Dec;43(4):607-617
pubmed: 27866580
Blood. 2015 Aug 27;126(9):1069-77
pubmed: 25964669
Blood. 2016 May 19;127(20):2391-405
pubmed: 27069254
J Allergy Clin Immunol. 2012 Sep;130(3):607-612.e9
pubmed: 22460074
J Allergy Clin Immunol. 2009 Dec;124(6):1319-25.e3
pubmed: 19910029
Stroke. 2017 Oct;48(10):2753-2759
pubmed: 28916673
Am J Hematol. 2017 Nov;92(11):1243-1259
pubmed: 29044676